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Background: India has a high burden of disease from hepatitis B virus (HBV), with 3.7 % point-prevalence, as well
as from hepatitis C virus (HCV), with 1–1.5 % prevalence. Societal ignorance about HBV and HCV in India limits the
potential for prevention and treatment efforts to bring these diseases under control. Since patients’ own knowledge
about their health condition may have important health consequences, this study sought to assess knowledge
levels among HBV and HCV patients referred to the virology laboratory of the Liver Foundation, West Bengal.
Methods: Patients who had tested positive for HBsAg or anti-HCV at government specialty clinics were invited to
enroll in the study when they presented for follow-up laboratory testing. Study participants completed a survey
that contained three multiple-choice questions about viral hepatitis etiology and five multiple-choice questions
about the consequences of HBV and HCV infection. Mean knowledge scores for male and female respondents were
compared, and comparisons were also made across different places of residence, age groups, education levels and
income levels. One-way ANOVA was used to test for significant differences.
Results: Among 520 study participants, the mean knowledge score was 4.76 on an eight-point scale.
Approximately 40 % of the study sample scored less than 4.0. Almost three-quarters of respondents correctly
responded to the question, “Which organ of the human body is affected by hepatitis?” while almost two-thirds
knew how hepatitis B is transmitted. Regarding consequences of HBV and HCV infection, less than one-third of
study participants answered correctly when asked, “What happens when one is infected with hepatitis B or C?”
Slightly more than two-thirds of people correctly answered the question about how hepatitis B is prevented. The
mean knowledge score varied across age groups (P = 0.0009), education levels (P = 0.0001) and monthly household
income levels (P = 0.0001). With higher levels of schooling and higher household income, there were corresponding
increases in knowledge scores.
Conclusion: There is room for improving knowledge of HBV and HCV etiology and consequences among patients
as well as healthcare workers in India. More awareness activities should be organized, accompanied by further
research to track whether knowledge scores improve over time.
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Viral hepatitis has emerged as a major health problem
worldwide, including in India. Among the five main
types of hepatitis viruses, hepatitis B virus (HBV) and
hepatitis C virus (HCV) are of the greatest concern due
to their burden of illness and death. HBV and HCV can
cause both acute and chronic disease [1, 2]. An esti-
mated 240 million people are chronically infected with
HBV (defined as hepatitis B surface antigen-positive for
at least 6 months) and more than 780,000 people die
every year due to complications of HBV, including cir-
rhosis and liver cancer [1, 3–7]. Between 130 and 150
million people globally are thought to have chronic
HCV infection. As with HBV, potential outcomes of
chronic HCV infection include liver cirrhosis and liver
cancer. Approximately 500,000 people die each year due
to HCV-related liver ailments [2, 7].
An estimated 100 million chronic HBV and HCV car-
riers reside in Southeast Asia [8–10]. Home to almost
one-fifth of the world’s population, India accounts for a
large proportion of the global HBV burden, with 10–
15 % of the entire pool of HBV carriers. It is considered
an intermediate endemic country, with a 3.7 % point-
prevalence [11, 12]. More than 40 million HBV carriers
live there; annually, one million Indians are at risk of
getting HBV infection, and about 100,000 deaths occur
due to HBV infection [3, 5]. Approximately one million
infants in India live with the lifetime risk of developing
chronic HBV infection [11, 13]. Due to its large popula-
tion, the country also accounts for a significant share of
the global HCV burden, with 1–1.5 % prevalence. An es-
timated 15 to 18 million people live with acute or
chronic HCV infection in India [14, 15]. About 20 % of
liver diseases in the country are associated with HCV in-
fection, and HBV infection accounts for an even larger
proportion of the burden of liver diseases [8].
HBV and HCV are bloodborne diseases, and know-
ledge about transmission pathways and preventive mea-
sures can help reduce the risk of acquiring both diseases.
Furthermore, appropriate medical treatment can lessen
the effects of HBV and can cure HCV. However, societal
ignorance in India about HBV and HCV limits the po-
tential for prevention and treatment efforts to bring both
epidemics under control [16].
Low knowledge about HBV and HCV may have ser-
ious consequences for patients and their families and
other contacts. Patients who lack adequate information
or are misinformed about HBV and HCV may not be
sufficiently prepared to make decisions that can protect
their health, including adhering to prescribed medical
treatments. Patients’ poor knowledge might also lead
them unknowingly to expose their family members and
others to HBV or HCV. Therefore, dissemination of cor-
rect information to patients as part of a holisticapproach to their health care might help them develop
good disease management strategies and might also con-
stitute an essential component of effective viral hepatitis
prevention programs, ultimately helping to reduce the
burden of disease and death in India.
Additional negative consequences might arise from
prevailing misconceptions about HBV and HCV, accord-
ing to field experiences reported by the Liver Founda-
tion, West Bengal (LFWB), an Indian nongovernmental
organization. These misconceptions may deter people
from seeking proper medical advice and may prompt
some of them to turn to folk medicines for treatment. In
the case of HIV, patients’ limited knowledge and wrong
perceptions about that disease have been linked to poor
treatment outcomes [17]. This finding raises the ques-
tion of whether a similar dynamic may undermine ef-
forts to treat HBV and HCV patients. Furthermore,
these patients may experience shame associated with the
stigmatized nature of these diseases, potentially leaving
them isolated and afraid to seek appropriate medical
care, particularly those with limited knowledge about
their health. Knowledge of the etiology and conse-
quences of HBV and HCV may thus empower them to
take an active part in their own treatment.
The present study was undertaken to assess HBV- and
HCV-infected Indian patients’ knowledge regarding
HBV and HCV etiology and consequences. The majority
of studies assessing knowledge, attitudes and practices
regarding HBV and HCV in low- and middle-income
countries have been conducted among medical and la-
boratory technicians [18–21], while a few have focused
specifically on HBV and HCV knowledge among the
general population [22, 23]. To the best of our aware-
ness, this is the first study to investigate Indian HBV and
HCV patients’ knowledge of the etiology and conse-
quences of HBV and HCV infection. The purpose of
the study was to acquire evidence that can help to in-
form the future direction of HBV and HCV control
efforts in the study location, West Bengal, and in




The Liver Foundation, West Bengal works to raise
awareness about HBV and HCV, liver disease and gen-
eral health issues. Since 2007, LFWB has been conduct-
ing awareness and health education meetings in schools,
colleges and community settings. In addition to the gen-
eral population, target audiences include patients, physi-
cians and other healthcare workers.
With the support of the Bristol-Myers Squibb Foundation
(BMSF), LFWB established a laboratory to provide low-cost
molecular virology and metabolic diagnosis for patients
Table 1 Questions put to study participants about viral hepatitis




d. Do not know
2. Which is the most severe disease affecting the liver?
a. Jaundice
b. Hepatitis B and C
c. Hepatitis A and E
d. Do not know
3. How is hepatitis B or C transmitted?
a. Through contaminated food and water
b. Through sneezing and coughing
c. Through contaminated blood
d. Do not know
4. What happens when one is infected with hepatitis B or C?
a. Jaundice will occur
b. Jaundice may not occur
c. Jaundice will never occur
d. Do not know
5. How is jaundice cured?
a. Wear “garland” of jaundice
b. Take complete bed rest
c. Take only boiled food
d. Take proper medical advice
6. What should be the diet during jaundice?
a. Completely vegetarian food
b. Completely boiled food (without oil and spices)
c. Glucose, sugarcane juice and fruits
d. Normal healthy diet (homemade)
7. What should one do when affected with jaundice?
a. Take leave from job and have complete bed rest
b. Do normal work
c. Do excess work
d. Do not know
8. How is hepatitis B or C prevented?
a. By isolating the infected person
b. By avoiding street food
c. Through vaccination and proper advice
d. Do not know
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the LFWB laboratory following a two-stage diagnostic
process. When a general physician has diagnosed a patient
with a liver problem, it is standard practice for the patient
to be referred to the speciality clinic of a government hos-
pital. A consultant at the specialty clinic may advise the pa-
tient to undergo serological testing for HBsAg and anti-
HCV, and patients who do so are tested at the same clinic.
Those patients who test positive for either disease marker
are then referred to the LFWB molecular virology labora-
tory for further testing.
For the purpose of this study, HBsAg-positive patients
referred to the LFWB laboratory from government hos-
pitals were considered by investigators to have a diagno-
sis of HBV, and similarly, anti-HCV-positive patients
were considered to have a diagnosis of HCV. Patients
with a diagnosis of HBV or HCV were invited to partici-
pate in the study at the time of their visit to the LFWB
laboratory if they also met the following study inclusion
criteria: (1) the patient was at least 18 years old, (2) the
patient had previously undergone no more than one
liver-related consultation with a certified physician at a
government hospital, and (3) the patient was visiting the
LFWB laboratory for the first time.
Patients who met these criteria and agreed to partici-
pate in the study were asked to immediately complete a
study survey at the central office of the LFWB, which is
adjacent to the laboratory. Study enrollment and data
collection took place between February 2014 and Janu-
ary 2015. To ensure that study participants fully com-
prehended all survey questions, study investigators
verbally administered the survey instrument in face-to-
face interviews and explained questions if required to do
so. The interviews were conducted in participants’ native
languages. Although Hindi and English were used in
some cases, Bengali, or “Bangla,” was used more often as
it is the native language of the province (West Bengal).
Survey instrument
Study data were collected using a two-part questionnaire
developed by investigators. The survey instrument was
validated by administering it to 20 randomly selected
HBV or HCV patients who fulfilled the study criteria. In
the first part of the survey instrument, the following pa-
tient profile information was collected: name, age, sex,
address, education background and monthly household
income. The second part of the survey instrument was
composed of eight multiple-choice questions: three
about viral hepatitis etiology and five about the conse-
quences of HBV and HCV infection. There were four
multiple-choice options for each question, among which
one was correct (Table 1).
Several questions used the term “jaundice” instead of
asking directly about HBV and HCV because most ofthe lay public in India, even paramedics, think of jaun-
dice as a liver disease while not being aware of viral
hepatitis.
Moreover, the questionnaire was categorized into two
parts, an etiology section with fewer questions and a
consequences section with more questions, as the survey
was conducted among infected patients who had had
one specialist consultation.
Scoring
When a respondent chose either an incorrect response,
multiple responses or “do not know,” the question was
scored as nil. Each correct response was given a score of
1. A respondent’s total score thus could range from 0 to 8.
Statistical analysis
Knowledge scores were calculated for individual study
participants, and descriptive statistics were generated
from these data. Knowledge scores then were considered
in relation to five sociodemographic factors: place of
residence, sex, age, education background and monthly
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ledge scores were compared across 19 districts and one
other area. For sex, male and female study respondent
scores were compared. Other comparisons were made
using five age groups, five education levels and five in-
come levels. One-way ANOVA was used to test for sig-
nificant differences between mean knowledge scores for
the categories associated with each sociodemographic
factor [24].
Ethics
Participation in this study was voluntary. Written con-
sent was obtained from all participants prior to study
enrollment.
Results
Among 603 patients invited to participate in the study,
520 agreed and completed surveys, for a response rate of
86.2 %. Respondents resided in 19 districts in West Ben-
gal, as well as in two neighboring states, Jharkhand and
Bihar, and one neighboring country, Bangladesh. How-
ever, more than half were from three districts: Kolkata
(23.5), North 24 Parganas (14.0) and South 24 Parganas
(15.8 %) (Table 2). The study population was composed
of 342 males and 178 females. The overall mean age was
36.7 years, ranging between 18 and 75 years of age (data
not shown). Forty-two percent of study participants re-
ported that the highest education level they had com-
pleted was middle school, while 11.7 of study
participants had completed high school and 24.1 % had
completed college or university. Almost 60 % of study
participants belonged to households earning less than
5546 INR (approximately 81 USD) per month.
Table 3 shows the proportions of study participants
providing correct, incorrect and “do not know” re-
sponses to the eight questionnaire items. Almost three-
quarters of respondents correctly responded to the ques-
tion, “Which organ of the human body is affected by
hepatitis?” while almost two-thirds knew how hepatitis B
is transmitted. Forty-six percent replied correctly when
asked, “Which is the most severe disease affecting the
liver?” Regarding consequences of HBV and HCV infec-
tion, less than one-third of study participants answered
correctly when asked, “What happens when one is in-
fected with hepatitis B or C?” Much larger proportions
of respondents replied correctly when they were asked,
“How is jaundice cured?” (72.1) and “What should be
the diet during jaundice?” (61.9 %). Slightly more than
two-thirds of participants correctly answered the ques-
tion about how hepatitis B or hepatitis C is prevented.
The mean knowledge score reported in this study was
4.76 on an eight-point scale. Approximately 40 % of the
study sample scored less than 4.0 (only half of the pos-
sible points). The mean score varied significantly acrossage groups (P = 0.009), with people aged 25–34 years
scoring the highest (5.04) and people aged 55 years and
older scoring the lowest (3.98). Mean scores also varied
significantly across education levels (P = 0.0001) and
monthly household income levels (P = 0.0001), increas-
ing with higher education as well as higher income
(Table 2).
When knowledge scores were disaggregated into eti-
ology and consequences, significant differences were ob-
served in both education (P = 0.0001) and household
income (P = 0.0001) domains (Table 4). At higher levels
of schooling and household income, knowledge scores in
both domains improved. Regarding the relationship be-
tween knowledge scores and age, significant variation
was found for knowledge about consequences of HBV
and HCV infection (p = 0.0001) but not for knowledge
about etiology. The highest knowledge score for the five
“consequences” questions was 3.17 among people aged
35–44 years, while the lowest knowledge score was 2.28
among people aged 55 years and older.
Discussion
The purpose of this study was to investigate knowledge
of HBV and HCV etiology and consequences among in-
fected patients in West Bengal, India. The study popula-
tion of 342 males and 178 females included a large
proportion of people who had a high school education
or less, and household income levels reported by study
participants were fairly low overall. The mean knowledge
score for all study participants was 4.76 on an eight-
point scale. Although significantly different knowledge
scores were seen across age groups, disaggregating the
“etiology” and “consequences” questions indicated that
age groups differed significantly only in regard to know-
ledge of HBV/HCV consequences. Positive correlations
were seen between HBV/HCV knowledge scores and
education levels, as well as between these scores and
household income levels.
Studies that have examined the association of
socioeconomic status with knowledge of lung cancer
and knowledge of stroke suggest a positive relationship
[25–27]. Another study showed that lower socioeco-
nomic status was associated with lower awareness about
the harmful effects of smoking [28]. The present study
found similar results: lower monthly household income
correlated with less knowledge of viral hepatitis etiology
and disease consequences, and knowledge scores in-
creased progressively across higher income strata. The
same pattern was found for educational attainment,
which is widely regarded as a proxy for socioeconomic
status [29]. We speculate that study participants with
lower socioeconomic status might have had less access
to information about HBV and HCV, including fewer
opportunities to visit healthcare facilities to obtain such
Table 2 Sociodemographic characteristics of the study
population and mean knowledge scores
Variable (%) N Mean score on 8-
point scale
P-value
District (n = 520)







Coochbehar 0.2 (1) 4.00























North 24 Pargana 14.0
(73)
5.14
North Dinajpur 0.6 (3) 3.00
Purulia 0.4 (2) 4.50
South 24 Pargana 15.8
(82)
4.02




Other 1.4 (7) 5.43











25 – 34 34.2
(178)
5.04
35 – 44 23.7
(123)
4.98






Table 2 Sociodemographic characteristics of the study
population and mean knowledge scores (Continued)
Education (n = 489)a























Total monthly household income (INR) (n = 399)c
Less than 1865 17.3
(30)
3.57 0.0001
1866 – 5546 40.6
(203)
4.48
5547 – 9248 25.3
(68)
5.13
9249 – 13 873 5.3
(39)
5.41
More than 13 873 11.5
(59)
6.10
a31 respondents did not answer the question about education
bRespondents who reported that they had received less than 4th standard
education were classified as “no formal education.”
c121 respondents did not answer the question about income
Table 3 Proportions of correct and incorrect responses on
eight-item questionnaire (N = 520)
Question Responses (%)
Correct Incorrect Do not know
Etiology
Which organ of the human
body is affected by hepatitis?
74.2 1.9 23.8
Which is the most severe
disease affecting the liver?
46.0 20.8 33.3




What happens when one is
infected with hepatitis B or C?
32.7 40.4 26.9
How is jaundice cured? 72.1 23.3 4.6
What should be the diet
during jaundice?
61.9 33.8 4.2
What should one do when
affected with jaundice?
58.1 33.7 8.3
How is hepatitis B or
C prevented?
67.9 10.8 21.3
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Table 4 Mean scores for knowledge of etiology and consequenses of hepatitis B and C, disaggregated by sociodemographic factors
Etiology
Max score = 3 (95 % confidence interval)
P value Consequences
Max score = 5 (95 % confidence interval)
P value
District (n = 520)
Bankura (n = 8) 1.25 (0.78 – 2.32) 0.517 2.25 (0.72 – 3.78) 0.089
Birbhum (n = 12) 2.00 (1.19 – 2.81) 2.92 (1.92 – 3.91)
Burdwan (n = 17) 1.59 (1.01 – 2.16) 2.53 (1.78 – 3.28)
Coochbehar (n = 1) 2.00 2.00
Darjiling (n = 1) 2.00 2.00
East Midnapore (n = 22) 2.00 (1.51 – 2.49) 3.45 (2.83 – 4.08)
Hooghly (n = 31) 1.84 (1.45 – 2.23) 3.22 (2.76 – 3.69)
Howrah (n = 39) 1.82 (1.49 – 2.14) 2.56 (2.056 – 3.07)
Jalpaiguri (n = 1) 2.00 2.00
Kolkata (n = 122) 1.99 (1.79 – 2.18) 3.14 (2.89 – 3.41)
Malda (n = 15) 2.07 (1.49 – 2.64) 2.81 (2.01 – 3.59)
Murshidabad (n = 33) 1.79 (1.37 – 2.21) 2.91 (2.43 – 3.38)
Nadia (n = 37) 1.76 (1.38 – 2.13) 3.08 (2.58 – 3.58)
North 24 Pargana (n = 73) 1.99 (1.74 – 2.23) 3.15 (2.88 – 3.42)
North Dinajpur (n = 4) 1.00 (−1.48 – 3.48) 2.00 (−2.97 – 6.87)
Purulia (n = 2) 2.00 (−10.71 – 14.71) 2.500 (−16.56 – 21.56)
South 24 Pargana (n = 82) 1.54 (1.28 – 1.79) 2.49 (2.18 – 2.79)
South Dinajpur (n = 4) 2.25 (0.73 – 3.77) 300 (1.16 – 4.84)
West Midnapore (n = 10) 1.60 (0.99 – 2.20) 2.60 (1.91 – 3.29)
Other (n = 7) 2.14 (1.02 – 3.27) 3.29 (2.13 – 4.45)
Sex (n = 520)
Male (n = 342) 1.79 (1.67 – 1.91) 0.200 2.93 (2.78 – 3.08) 0.895
Female (n = 178) 1.92 (1.76 – 2.08) 2.92 (2.71 – 3.12)
Age (years) (n = 520)
< 25 (n = 80) 2.02 (1.79 – 2.26) 0.151 2.68 (2.36 – 2.99) 0.0001
25 – 34 (n = 178) 1.90 (1.75 – 2.05) 3.14 (2.94 – 3.33)
35 – 44 (n = 123) 1.81 (1.62 – 2.00) 3.17 (2.91 – 3.43)
45 – 54 (n = 79) 1.63 (1.37 – 1.89) 2.81 (2.53 – 3.09)
55+ (n = 60) 1.70 (1.38 – 2.02) 2.28 (1.89 – 2.68)
Education (n = 489)a
No formal educationb 0.93 (0.29 – 1.58) 0.0001 1.87 (1.24 – 2.49) 0.0001
Completed primary education (4th standard) 1.31 (1.08 – 1.54) 2.25 (1.99 – 2.50)
Completed middle school (8th standard) 1.79 (1.64 – 1.94) 2.99 (2.79 – 3.18)
Completed high school (12th standard) 2.21 (1.95 – 2.47) 3.21 (2.93 – 3.49)
Completed college/university or above 2.49 (2.37 – 2.61) 3.69 (3.49 – 3.89)
Total monthly household income (INR) (n = 399)c
Less than 1865 (n = 30) 1.53 (1.05 – 2.01) 0.0001 2.03 (1.51- 2.56) 0.0001
1866 – 5546 (n = 203) 1.61 (1.46 – 1.76) 2.87 (2.67 – 3.06)
5547 – 9248 (n = 68) 1.99 (1.73 – 2.24) 3.15 (2.85 – 3.45)
9249 – 13 873 (n = 39) 2.15 (1.88 – 2.43) 3.26 (2.86 – 3.65)
More than 13 873 (n = 59) 2.36 (2.12 – 2.59) 3.75 (3.44 – 4.05)
a31 respondents did not answer the question about education
bRespondents who reported that they had received less than 4th standard education were classified as “no formal education”
c121 respondents did not answer the question about income
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facilities and a lack of transportation might be related
reasons for low knowledge among these patients, who
might benefit from health policies and programs that
consider these factors when developing HBV and HCV
awareness campaigns.
If patients from lower socioeconomic strata are more
inclined than other patients to utilize traditional healing
practices, this may also help to explain the differences in
knowledge scores, since traditional healing practices
have the potential to foster misconceptions about HBV
and HCV. We observed that 15 % of study participants
who responded incorrectly to a question about a cure
for jaundice believed in such local folk remedies as wear-
ing a “jaundice-garland” to cure it. Twenty-one percent
of all respondents believed that glucose in either a com-
mercially available powder form or in the form of sugar
cane should be the only diet of a person with jaundice.
More research is needed to determine whether such be-
liefs and practices negatively affect HBV and HCV pa-
tients’ health outcomes, and to identify interventions
that may improve the situation. There may be valuable
guidance in other health fields; for example, research has
been conducted on initiatives to train traditional healers
in diabetes prevention and care in Cameroon, and to in-
volve traditional healers in the scale-up of antiretroviral
treatment for people living with HIV in Lesotho [30, 31].
With respect to age, we found that study participants
aged 25–34 years had the highest overall mean know-
ledge score, and that study participants aged 35–44 years
had the highest knowledge scores for HBV/HCV conse-
quences, while those aged 55 years and older scored the
lowest in both cases. The literacy rate in India increased
from 12 % at the end of British rule in 1947 to 74 % in
2011, [32] which might partially explain our age-related
study findings. However, there is still the question of
why knowledge scores among study participants aged
18–24 years were also fairly low. There is a need for re-
search that elucidates the relationship between age and
HBV/HCV knowledge in India, as well as research that
identifies key knowledge pathways for different age
groups.
Provider-related factors should also be considered in
relation to study participants’ low overall knowledge
scores. All study participants were newly diagnosed with
HBV or HCV, and all of them had received only one
consultation related to the diagnosis. The consultation
might not have been sufficient to provide a patient with
adequate HBV or HCV knowledge. Previous studies
have reported that patients’ inability to understand med-
ical jargon, their fear of asking a medical practitioner for
explanations about terminology, inadequate consultation
time to address all queries due to over-burdened sched-
ules, unfriendly healthcare staff and hospitality issues,patients’ fears of verbal abuse by physicians and allied
healthcare staff, and their anxiety about and fear of the
disease are major barriers to effective communication
between patients and healthcare staff [33–35]. These
barriers could be presumed to affect patients’ knowledge,
potentially leading to misconceptions related to blood-
borne viral hepatitis and increasing their health risks. A
comprehensive disease prevention program should take
such considerations into account.
Poor knowledge and misconceptions about HBV and
HCV among general practitioners and other health
workers might be another reason for low patient know-
ledge. Low levels of knowledge of bloodborne viral hepa-
titis among healthcare workers and medical students
have been reported in studies conducted in developing
countries. Setia et al., for instance, reported that 31 of
medical practitioners, 38 of dental practitioners and
49 % of nurses claimed to have been vaccinated against
hepatitis C, although no such vaccine exists [36]. An-
other study, conducted among students in four medical
colleges in Pakistan, revealed that 73 % did not get
screened for bloodborne hepatitis following a needlestick
injury [37]. Studies have furthermore reported that dis-
crimination and ostracism have originated from misin-
formation disseminated by healthcare personnel [38–41].
Informed doctors as well as other healthcare workers
can play an important role in promoting accurate infor-
mation about hepatitis and jaundice to patients. In doing
so, health providers might also help reduce stigma for
HBV and HCV patients across all settings, including op-
erating rooms.
We suggest that these and other studies support the
need to improve patients’ hepatitis knowledge through
more effective HBV and HCV education programs tar-
geting patients, healthcare practitioners and the general
population alike. Such programs are particularly import-
ant in a country such as India, where jaundice is re-
ported as a disease along with hepatitis in the National
Sample Survey report and it is common for general
practitioners to address jaundice instead of hepatitis as a
disease, resulting in a society where yellowing of the eyes
and urine is equated with jaundice as a synonym for
hepatitis [42]. The National Program for Prevention and
Control of Viral Hepatitis in India is not in action, even
now, only a committee that was formed in 2012 to for-
mulate such a control program in viral hepatitis [43].
National Family Health Survey, India reports reveal that
liver disease, including hepatitis, is not a national public
health priority; therefore more clarity in thought is
needed from policy-makers [44].
A 2013 review concluded that educational interven-
tions have significant beneficial effects on persons who
are at risk for or have been diagnosed with HBV or
HCV. These effects extend to disease knowledge and
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disease, receiving vaccinations, and being willing to
commence and adhere to treatment [45]. It is recognized
that there is limited knowledge about infectious diseases
in general, including viral hepatitis, particularly among
people with a low educational and socioeconomic level.
Therefore, more current information locally can lead to
focused action for knowledge empowerment,which is
also mentioned in the World Health Organization’s first-
ever Global Health Sector Strategy on Viral Hepatitis
[46]. Hence assessments of HBV and HCV patients’
knowledge levels are the necessary starting point in the
process of determining how to overcome knowledge-
related barriers to treatment and the prevention of on-
ward transmission. Our present study offers important
insights in this regard, and is notable for not being pre-
ceded by any other published research of this kind relat-
ing to an Indian population. Further research is needed,
as the full population of HBV and HCV patients in India
is diverse, with patients representing a wide range of cul-
tural, socioeconomic and other backgrounds that may
inform their knowledge and perspectives regarding viral
hepatitis.
Some of the limitations of this study may have impli-
cations for the generalizability of its findings. More than
half of the individuals who made up the relatively small
sample of 520 reported that they lived in the districts of
Kolkata, North 24 Pargana and South 24 Pargana. The
heavy representation of these districts may be related to
the large number of referrals that the LFWB receives,
mainly from speciality clinics of government hospitals in
Kolkata. Furthermore, the study did not include many
participants from higher-income households. Almost
60 % of study participants reported having a monthly
household income under 5547 INR, while monthly per
capita income for West Bengal is INR 6575, and the na-
tional monthly per capita income is INR 7378 [47]. A
larger study population, more evenly distributed across
districts might have contributed to a better understand-
ing of knowledge among HBV and HCV patients.Conclusion
The knowledge gaps observed among HBV and HCV
patients in this study suggest a need for further research
and for educational interventions that take into account
the needs of diverse populations in India, including
members of different age groups and socioeconomic
strata. A country-wide focus on correct knowledge dis-
semination by healthcare professionals, improved
physician-patient communication and the introduction
of a positive health culture based on scientifically proven
evidence can contribute to sustained viral hepatitis con-
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